Back to search

Georgia Institute of Technology

To Drink or Not TO Drink: Clinically relevant models of alcohol consumption and liver disease to Inform Dynamic and Interpretable Community Alcohol Policy

Abstract

dc:description.abstract

Alcohol-attributable liver disease rates have been on the rise globally and in the United States over the past two decades. Each disease event in the general population carries a significant cost for the individual, their community, and society at large. This thesis considers clinically relevant models that incorporate the regenerative abilities of the liver to project disease morbidity and mortality, expected impact of societal and individual trauma, future expected costs, and that can inform decision support tools for strategies to mitigate the worst effects are of critical importance. We first study the general projection problem for disease morbidity and mortality at the population level for high-risk drinking. With evolving drinking rates, we project how changing population dynamics and drinking rates will affect morbidity and mortality and consider the potential impact of policy solutions similar to the ongoing attempt to control tobacco use in the United States. The incidence of alcohol-associated liver cirrhosis and cancer is expected to continue to increase and significant policy interventions rising to the level of interventions on smoking currently in place will stabilize but not eliminate current mortality levels. We next deepen our investigation to consider the combined impact of the liver's regenerative ability and individual consumption choices to understand the impact of events and interventions that cause either increases or decreases in drinking on population level morbidity, mortality, and costs including expected costs of health care, labor-related economic losses, and consumption related losses due to mortality. COVID-19 related increases in drinking are associated with limited increases in short term mortality but significant rises in long-term morbidity, mortality, and costs. By incorporating the liver's regenerative ability, we expand the horizon of analyzable strategies and decisions to include those that impact drinkers who have not yet presented with end-stage liver disease and more fully consider the impact of harm-reduction strategies in the consideration of alcohol policy.

Degree

thesis:*
Level thesis:degree_level
Doctoral
Department dc:contributor.department
Industrial and Systems Engineering
Grantor dc:publisher
Georgia Institute of Technology
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Julien, Jovan
Advisors dc:contributor.advisor
  • Ayer, Turgay
  • Chhatwal, Jagpreet
Committee members dc:contributor.committeemember
  • Goldsman, David
  • Steimle, Lauren
  • Garcia, Gian-Gabriel

Subjects

dc:subject × 5

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1853/67278

Chain of custody

source
Harvested from
Georgia Tech
Base URL
repository.gatech.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Julien, Jovan. To Drink or Not TO Drink: Clinically relevant models of alcohol consumption and liver disease to Inform Dynamic and Interpretable Community Alcohol Policy. Doctoral thesis, Georgia Institute of Technology, 2022. http://hdl.handle.net/1853/67278